October 6, 2015

Novozymes acquires Pacific Vet Group-USA, Inc.

 

Novozymes has announced the acquisition of Pacific Vet Group-USA, Inc. (PVG), a developer of probiotics for animals, at an undisclosed fee.

Based in Arkansas, US, PVG possesses a grounded knowledge in probiotic applications for poultry and a pipeline for the poultry hatchery segment.

"PVG is a great fit with Novozymes as we continue to build our position as the leading innovation partner in probiotics for animals," said Helle Warrer Poulsen, Novozymes' vice-president for animal health and nutrition.

"With PVG, we will get access to a promising pipeline and early product concepts targeted at the hatchery segment in the US. The PVG team has strong ties to academia and industry, and brings experience in the development of probiotics for animals. They will provide Novozymes with valuable insights and expertise, and further strengthen our partnerships."

PVG has 23 employees, primarily in research and application development. The company was founded in 2008 around technology developed by the University of Arkansas Division of Agriculture. Primarily sold in the US, its current products are based on beneficial bacteria - mainly lactic acid bacteria - and work to improve gut health in poultry.

The acquisition of PVG is not expected to impact Novozymes' financial outlook for 2015.